-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下: 在审阅盈利报告后,我们根据44倍的预期市盈率,将12个月目标股价上调44美元至245美元。该预期市盈率为44倍,基于我们2027年每股收益预期5.56美元(上调0.05美元)。这一估值较历史平均水平有较大溢价,主要得益于人工智能举措带来的卓越息税前利润和利润率增长。此外,鉴于年初的强劲开局,我们将2026年每股收益预期上调0.22美元至4.64美元。XPO第一季度的业绩令人鼓舞,公司营收和盈利均超出预期,同时实现了低于0.2%的历史最低索赔率。公司在多个领域均表现出色:提升服务质量、获得盈利市场份额、实现高于市场平均水平的价格增长,并通过专有人工智能技术显著提高成本效益。我们预计这一强劲业绩将持续,2026年和2027年利润率和盈利均有望实现健康增长。然而,我们认为XPO的估值已基本反映出这些改善,其目前的交易价格比五年平均预期市盈率24倍高出98%。我们维持“持有”评级。
Related Articles
Collins Foods Confirms Partnership Arrangement Condition Met for Taco Bell Transition
Collins Foods (ASX:CKF) said conditions precedent for the transition of 20 Taco Bell restaurants to a new partnership arrangement between an affiliated company of Taco Bell and Restaurant Brands Australia have been satisfied, according to a Friday Australian bourse filing.The company said the transaction remains subject to other customary conditions, including landlord consents, a store-based employment threshold, and Australian Competition and Consumer Commission (ACCC) clearance, with completion expected between June and August, depending on regulatory approval timelines.
NZX Q1 Revenue Rises 5%
NZX (NZE:NZX) reported first-quarter revenue of NZ$32.7 million, up 5% from NZ$31.1 million in the year-ago period, according to a Friday filing on the bourse.The number of total listed securities on the exchange as of March 31 fell 1.8% year over year to 323, per the filing.
Avita Medical Appoints CEO, Chair
Avita Medical (ASX:AVH) has appointed Cary Vance as chief executive, effective immediately, according to a Friday Australian bourse filing.Vance has been acting as interim CEO since October 2025, per the filing.The company also appointed Jan Stern Reed as chair with immediate effect, the filing added.